首页|依达拉奉注射液联合阿替普酶静脉溶栓对急性缺血性脑卒中患者氧化型低密度脂蛋白、缺血修饰白蛋白水平的影响

依达拉奉注射液联合阿替普酶静脉溶栓对急性缺血性脑卒中患者氧化型低密度脂蛋白、缺血修饰白蛋白水平的影响

扫码查看
目的 分析依达拉奉注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中患者的临床效果。方法 选取医院2021年3月至2023年2 月收治的76例急性缺血性脑卒中患者为研究对象,根据随机数字表法将其分为对照组(38 例,阿替普酶静脉溶栓治疗)和研究组(38 例,依达拉奉注射液联合阿替普酶静脉溶栓治疗)。比较两组的治疗效果。结果 研究组的治疗总有效率显著高于对照组,差异具有统计学意义(P<0。05)。治疗后,研究组的氧化型低密度脂蛋白(Ox-LDL)、缺血修饰白蛋白(IMA)、脂蛋白相关磷脂酶A2(Lp-PLA2)、促红细胞生成素(EPO)及簇集蛋白(CLU)水平低于对照组,差异具有统计学意义(P<0。05)。治疗后,研究组的N-乙酰天门冬氨酸/肌酸(NAA/Cr)高于对照组,胆碱复合物/肌酸(Cho/Cr)低于对照组,胼胝体侧束、下额枕束向异性分数大于对照组,差异具有统计学意义(P<0。05)。结论 依达拉奉注射液联合阿替普酶静脉溶栓治疗急性缺血性脑卒中患者的效果显著,有助于调节机体血清学指标,促进神经功能恢复。
Effects of edaravone injection combined with alteplase intravenous thrombolysis on the levels of oxidized low-density lipoprotein and ischemia modified albumin in patients with acute ischemic stroke
Objective To analyze the clinical effect of edaravone injection combined with alteplase intravenous thrombolysis in the treatment of patients with acute ischemic stroke.Methods A total of 76 patients with acute ischemic stroke admitted in the hospital from March 2021 to February 2023 were selected as the research objects.According to the random number table method,the patients were divided into control group(38 cases,alteplase intravenous thrombolytic therapy)and study group(38 cases,edaravone injection combined with alteplase intravenous thrombolytic therapy).The therapeutic effects of the two groups were compared.Results The total effective rate of treatment in the study group was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of oxidized low-density lipoprotein(Ox-LDL),ischemia modified albumin(IMA),lipoprotein-associated phospholipase A2(Lp-PLA2),erythropoietin(EPO)and clusterin(CLU)in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the N-acetylaspartic acid/creatine(NAA/Cr)in the study group was higher than that in the control group,the choline-containing compounds/creatine(Cho/Cr)was lower than that in the control group,and the anisotropic scores of corpus callosum and inferior fronto-occipital fasciculus were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion The edaravone injection combined with alteplase intravenous thrombolysis in the treatment of patients with acute ischemic stroke has a significant effect,it is helpful to regulate the body's serological indicators and promote the recovery of neurological function.

acute ischemic strokeedaravone injectionalteplaseintravenous thrombolysisneurological function

范志阳、马娜、赵伟燕

展开 >

濮阳县人民医院全科医学科,河南 濮阳,457000

濮阳市人民医院神经内科,河南 濮阳,457000

濮阳县人民医院神经内科,河南 濮阳,457000

急性缺血性脑卒中 依达拉奉注射液 阿替普酶 静脉溶栓 神经功能

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(29)